Literature DB >> 20650261

The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway.

Mingzhu Liu1, Yong Yang, Can Wang, Lidong Sun, Chuanzhong Mei, Wantong Yao, Yonglei Liu, Yinghong Shi, Shuangjian Qiu, Jia Fan, Xiumei Cai, Xiliang Zha.   

Abstract

Epidermal growth factor receptor variant III (EGFRvIII), the most common EGFR mutation, is associated with cell migration of glioblastoma multiforme (GBM) cases; however, the mechanism has not been elucidated. In this study, we found that the EGFRvIII-promoted glioma cell migration was closely linked to high levels of tyrosine phosphorylation in focal adhesion kinase (FAK) Y397. We also demonstrated that EGFRvIII formed a complex with FAK, resulting in enhanced tyrosine phosphorylation levels of FAK Y397 and EGFR Y1068. After knockdown of FAK expression via anti-FAK shRNA, the U87ΔEGFR cell migration was significantly inhibited, accompanying with the reduced phosphorylation levels of extracellular signal-regulated kinase (ERK1/2). Furthermore, the role of ERK1/2 in FAK-regulated cell migration was confirmed. Taken together, our results suggest that FAK and its downstream molecule ERK were involved in EGFRvIII-promoted glioma cell migration in U87ΔEGFR cells. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650261     DOI: 10.1016/j.abb.2010.07.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.

Authors:  Qifan Zheng; Lei Han; Yucui Dong; Jing Tian; Wei Huang; Zhaoyu Liu; Xiuzhi Jia; Tao Jiang; Jianning Zhang; Xia Li; Chunsheng Kang; Huan Ren
Journal:  Neuro Oncol       Date:  2014-05-25       Impact factor: 12.300

2.  Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.

Authors:  Fadila Guessous; Yanzhi Yang; Elizabeth Johnson; Lukasz Marcinkiewicz; Matthew Smith; Ying Zhang; Alexander Kofman; David Schiff; James Christensen; Roger Abounader
Journal:  Mol Cancer Ther       Date:  2011-12-21       Impact factor: 6.261

3.  EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications.

Authors:  S A Greenall; J F Donoghue; M Van Sinderen; V Dubljevic; S Budiman; M Devlin; I Street; T E Adams; T G Johns
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

4.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

5.  Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells.

Authors:  Genevieve L Weber; Marie-Odile Parat; Zev A Binder; Gary L Gallia; Gregory J Riggins
Journal:  Oncotarget       Date:  2011-11

6.  Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry.

Authors:  Tianyao Guo; Xiaowei Wang; Maoyu Li; Haiyan Yang; Ling Li; Fang Peng; Xianquan Zhan
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 7.  Molecular biology of gliomas: present and future challenges.

Authors:  R Altieri; A Agnoletti; F Quattrucci; D Garbossa; F M Calamo Specchia; M Bozzaro; R Fornaro; C Mencarani; M Lanotte; R Spaziante; A Ducati
Journal:  Transl Med UniSa       Date:  2014-04-08

8.  Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia.

Authors:  Fei-Fei Wang; Ming-Zhu Liu; Yi Sui; Qing Cao; Bo Yan; Mei-Ling Jin; Xi Mo
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

9.  Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901.

Authors:  Li Dan; Ding Jian; Lin Na; Wang Xiaozhong
Journal:  Onco Targets Ther       Date:  2012-10-23       Impact factor: 4.147

10.  Combining molecular targeted agents with radiation therapy for malignant gliomas.

Authors:  Claudia Scaringi; Riccardo Maurizi Enrici; Giuseppe Minniti
Journal:  Onco Targets Ther       Date:  2013-08-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.